We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Stalls Generic Plavix Launch In Germany

Law360 (July 17, 2008, 12:00 AM EDT) -- The launch of a generic version of the blockbuster blood-thinning drug Plavix will be delayed in Germany until the German government can sort out a challenge from Plavix maker Sanofi-Aventis SA.

Andreas Rummelt, the chief executive of Novartis AG's Sandoz generics division, announced the delay Thursday during the company's half-year results update.

Novartis' Sandoz, along with a privately held German firm, is set to sell the Plavix generic under a distribution agreement with Schweizerhall Holding Ltd., a Swiss-based pharmaceutical company, Dow Jones reported.

The German Federal...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.